Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Otocap VT is an oral nutraceutical supplement developed by Centaur Pharmaceuticals (The Centaur Company) to support inner ear health, maintain balance, and manage symptoms of vertigo and dizziness. It is formulated as a capsule containing a synergistic combination of ten active ingredients: alpha lipoic acid, ginkgo biloba extract, ginseng extract, benfotiamine, pyridoxal 5'-phosphate, L-methylfolate, molybdenum, selenium, vitamin D, and vitamin B12. These components work together to provide robust antioxidant protection, improve microcirculation to the inner ear, support healthy nerve function, and replenish essential nutrient reserves.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Otocap VT.